Paluri, Ravi
Madan, Ankit
Li, Peng
Jones, Benjamin
Saleh, Mansoor
Jerome, Mary
Miley, Deborah
Keef, Jennifer
Robert, Francisco
Clinical trials referenced in this document:
Documents that mention this clinical trial
Phase 1b trial of nintedanib in combination with bevacizumab in patients with advanced solid tumors
https://doi.org/10.1007/s00280-018-3761-y
Funding for this research was provided by:
Comprehensive Cancer Center, University of Alabama at Birmingham (Cancer center core grant(CA 13148))
Boehringer Ingelheim
Article History
Received: 7 September 2018
Accepted: 29 November 2018
First Online: 2 January 2019
Compliance with ethical standards
:
: Dr. Francisco Robert: He is a member of speaker bureau for Boehringer Ingelheim. He is not involved with any of the drugs in this clinical study. No affiliations with or involvement in any organization or entity with any financial interest. All the authors declare that they have no potential conflicts of interest.